These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21872481)

  • 21. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
    Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary evaluations of the undesirable patient dose from a BNCT treatment at the ENEA-TAPIRO reactor.
    Ferrari P; Gualdrini G; Nava E; Burn KW
    Radiat Prot Dosimetry; 2007; 126(1-4):636-9. PubMed ID: 17704505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
    Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The filter/moderator arrangement-optimisation for the boron-neutron capture therapy (BNCT).
    Tracz G; Dabkowski L; Dworak D; Pytel K; Woźnicka U
    Radiat Prot Dosimetry; 2004; 110(1-4):827-31. PubMed ID: 15353754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different MC techniques to evaluate BNCT dose profiles in phantom exposed tovarious neutron fields.
    Durisi E; Koivunoro H; Visca L; Borla O; Zanini A
    Radiat Prot Dosimetry; 2010 Mar; 138(3):213-22. PubMed ID: 19939825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAGIC polymer gel for dosimetric verification in boron neutron capture therapy.
    Uusi-Simola J; Heikkinen S; Kotiluoto P; Serén T; Seppälä T; Auterinen I; Savolainen S
    J Appl Clin Med Phys; 2007 Apr; 8(2):114-23. PubMed ID: 17592463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined TL and 10B-alanine ESR dosimetry for BNCT.
    Bartolotta A; D'Oca MC; Lo Giudice B; Brai M; Borio R; Forini N; Salvadori P; Manera S
    Radiat Prot Dosimetry; 2004; 110(1-4):627-30. PubMed ID: 15353720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion.
    Yanagie H; Kumada H; Nakamura T; Higashi S; Ikushima I; Morishita Y; Shinohara A; Fijihara M; Suzuki M; Sakurai Y; Sugiyama H; Kajiyama T; Nishimura R; Ono K; Nakajima J; Ono M; Eriguchi M; Takahashi H
    Appl Radiat Isot; 2011 Dec; 69(12):1854-7. PubMed ID: 21752660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A toolkit for epithermal neutron beam characterisation in BNCT.
    Auterinen I; Serén T; Uusi-Simola J; Kosunen A; Savolainen S
    Radiat Prot Dosimetry; 2004; 110(1-4):587-93. PubMed ID: 15353713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the COG and MCNP codes in computational neutron capture therapy modeling, Part I: boron neutron capture therapy models.
    Culbertson CN; Wangerin K; Ghandourah E; Jevremovic T
    Health Phys; 2005 Aug; 89(2):127-34. PubMed ID: 16010123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective dose evaluation for BNCT brain tumor treatment based on voxel phantoms.
    Wang JN; Lee KW; Jiang SH
    Appl Radiat Isot; 2014 Jun; 88():55-8. PubMed ID: 24411557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the irradiation field at the research reactor TRIGA Mainz for BNCT.
    Duvinage C; Nagels S; Hampel G; Kratz JV; Aguilar AL; Minouchehr S; Otto G; Schmidberger H; Schütz C; Vogtländer L; Wortmann B
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S242-6. PubMed ID: 19380234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of the TAPIRO BNCT epithermal facility.
    Burn KW; Colli V; Curzio G; d'Errico F; Gambarini G; Rosi G; Scolari L
    Radiat Prot Dosimetry; 2004; 110(1-4):645-9. PubMed ID: 15353724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DEVELOPMENT OF A MULTIMODAL MONTE CARLO BASED TREATMENT PLANNING SYSTEM.
    Kumada H; Takada K; Sakurai Y; Suzuki M; Takata T; Sakurai H; Matsumura A; Sakae T
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):286-290. PubMed ID: 29087501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioneutronics: Thermal scattering in organics tissues and its impact on BNCT dosimetry.
    Ramos RL; Gonçalves-Carralves ML; Cantargi F
    Appl Radiat Isot; 2015 Oct; 104():55-9. PubMed ID: 26141296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of sealed D-T neutron generator as neutron source for liver BNCT and its beam shaping assembly.
    Liu Z; Li G; Liu L
    Appl Radiat Isot; 2014 Apr; 86():1-6. PubMed ID: 24448270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A microdosimetric approach to the thermal neutron fluence prescription for clinical BNCT.
    Kim EH; Rhee CH
    Radiat Prot Dosimetry; 2004; 112(3):377-83. PubMed ID: 15385681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo optimisation of a BNCT facility for treating brain gliomas at the TAPIRO reactor.
    Nava E; Burn KW; Casalini L; Petrovich C; Rosi G; Sarotto M; Tinti R
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):475-81. PubMed ID: 16604681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Numerical assessment of radiation binary targeted therapy for HER-2 positive breast cancers: advanced calculations and radiation dosimetry.
    Sztejnberg Gonçalves-Carralves ML; Jevremovic T
    Phys Med Biol; 2007 Jul; 52(14):4245-64. PubMed ID: 17664606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.